Decreased needs for hospital care and antibiotics in children with advanced HIV-1 disease after protease inhibitor-containing combination therapy

被引：13
|
作者：
Canani, RB [1 ]
Spagnuolo, MI [1 ]
Cirillo, P [1 ]
Guarino, A [1 ]
机构：
[1] Univ Naples Federico II, Dept Pediat, Naples, Italy
来源：
AIDS | 1999年 / 13卷 / 08期
关键词：
D O I：
10.1097/00002030-199905280-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1005 / 1006
页数：2
相关论文
共 37 条
  • [21] Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor
    Ho, Sarah K.
    Perez, Elena E.
    Rose, Stephanie L.
    Coman, Roxana M.
    Lowe, Amanda C.
    Hou, Wei
    Ma, Changxing
    Lawrence, Robert M.
    Dunn, Ben M.
    Sleasman, John W.
    Goodenow, Maureen M.
    AIDS, 2009, 23 (13) : 1631 - 1640
  • [22] Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen
    Landay, AL
    Spritzler, J
    Kessler, H
    Mildvan, D
    Pu, M
    Fox, L
    O'Neil, D
    Schock, B
    Kuritzkes, D
    Lederman, MM
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (10): : 1444 - 1454
  • [23] Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients
    De Wit, S
    Boulmé, R
    Poll, B
    Schmit, JC
    Clumeck, N
    AIDS, 2004, 18 (17) : 2330 - 2331
  • [24] Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: a retrospective cohort study
    Bongiovanni, M
    Bini, T
    Tordato, F
    Cicconi, P
    Melzi, S
    Repetto, D
    Sollima, S
    Rusconi, S
    Monforte, AD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 171 - 174
  • [25] Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children
    Resino, S
    Sánchez-Ramón, S
    Correa, R
    Navarro, ML
    Bellón, JM
    Muñoz-Fernández, MA
    MEDICINA CLINICA, 2003, 120 (11): : 417 - 420
  • [26] Efficient suppression of minority quasispecies of drug-resistant viruses present at primary HIV-1 infection by boosted protease inhibitor containing antiretroviral therapy
    Metzner, K.
    Rauch, P.
    von Wyl, V.
    Kuster, H.
    Boeni, J.
    Weber, R.
    Guenthard, H.
    SWISS MEDICAL WEEKLY, 2009, 139 (9-10) : 41S - 41S
  • [27] No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy
    Lajaunie, Rebecca
    Cuzin, Lise
    Palich, Romain
    Makinson, Alain
    Bani-Sadr, Firouze
    Duvivier, Claudine
    Arvieux, Cedric
    Rey, David
    Poizot-Martin, Isabelle
    Delpierre, Cyril
    Delobel, Pierre
    Martin-Blondel, Guillaume
    HIV MEDICINE, 2022, 23 (03) : 301 - 306
  • [28] Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa
    Rossouw, Theresa M.
    Feucht, Ute D.
    Melikian, George
    van Dyk, Gisela
    Thomas, Winifred
    du Plessis, Nicolette M.
    Avenant, Theunis
    PLOS ONE, 2015, 10 (07):
  • [29] Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa
    Wallis, Carole L.
    Mellors, John W.
    Venter, Willem D. F.
    Sanne, Ian
    Stevens, Wendy
    AIDS RESEARCH AND TREATMENT, 2011, 2011
  • [30] Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children:: a prospective cohort study
    Resino, S
    Bellón, JM
    Ramos, JT
    Gonzalez-Rivera, M
    de José, MI
    González, MI
    Gurbindo, D
    Mellado, MJ
    Cabrero, E
    Muñoz-Fernández, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (05) : 921 - 931
1234